Table 2 Patient characteristics at baseline (complete case analysis)
Patient characteristics | Intervention (n = 258) | Control (n = 247) |
|---|---|---|
Mean age (year (SD)) | 73 (9.7) | 72 (9.1) |
Sex | ||
Male | 142 (55%) | 129 (52%) |
Female | 116 (45%) | 118 (48%) |
Retired | 225 (87%) | 201 (81%) |
Long-term indication for oral anticoagulation therapy | ||
atrial fibrillation / flutter | 211 (82%) | 187 (76%) |
recurrent venous thromboembolism | 17 (6%) | 23 (9%) |
recurrent pulmonary embolism | 3 (1%) | 6 (2%) |
mechanical heart prosthesis | 20 (8%) | 20 (8%) |
intracardiac thrombus | 2 (1%) | 1 (1%) |
other indication | 5 (2%) | 10 (4%) |
Antithrombotic medicationa | ||
Coumarin | 242 (94%) | 232 (94%) |
Dabigatran | 8 (3%) | 1 (0.5%) |
Rivaroxaban | 6 (2%) | 11 (4%) |
acetylsalicylic acid | 2 (1%) | 2 (1%) |
no antithrombotic medication | 0 (0%) | 1 (0.5%) |
INR self-measuring and dose adjustment (for coumarins only) | 27 (11%) | 35 (14%) |
Patients with migration background | 27 (11%) | 14 (6%) |
EQ-5D score (SD) | 0.83 (0.21) | 0.80 (0.25) |